IDENTIFICATION OF INTERACTION PARTNERS AND SUBSTRATES · Cyclin A1 Interaction Partners - 5 - The...
Transcript of IDENTIFICATION OF INTERACTION PARTNERS AND SUBSTRATES · Cyclin A1 Interaction Partners - 5 - The...
Cyclin A1 Interaction Partners
- 1 -
IDENTIFICATION OF INTERACTION PARTNERS AND SUBSTRATES
OF THE CYCLIN A1/CDK2 COMPLEX
Sven Diederichs1, Nicole Bäumer1, Ping Ji1, Stephan K. Metzelder1, Gregory E.
Idos1,2, Thomas Cauvet1, Wenbing Wang1, Jörg Gromoll3, Mark G. Schrader4, H.
Phillip Koeffler2, Wolfgang E. Berdel1, Hubert Serve1 and Carsten Müller-Tidow*1
1Department of Medicine, Hematology/Oncology, University of Münster, Münster,
Germany
2Division of Hematology/Oncology, Cedars-Sinai Research Institute/UCLA
School of Medicine, Los Angeles, CA
3Institute of Reproductive Medicine, University of Münster, Münster, Germany
4Department of Urology, University Hospital Benjamin Franklin, Berlin, Germany
Running title: Cyclin A1/CDK2 interaction partners in testis
Keywords:
Cyclin A1, CDK2, Cell Cycle, Testis, Meiosis, Spermatogenesis, Leukemia
*Please address correspondence to: Carsten Müller-Tidow
Department of Medicine, Hematology/Oncology; University of Münster
Domagkstr. 3; D-48129 Münster; Germany
Phone: +49-251-835-6229
Fax: +49-251-835-2673
Email: [email protected]
JBC Papers in Press. Published on May 24, 2004 as Manuscript M401708200
Copyright 2004 by The American Society for Biochemistry and Molecular Biology, Inc.
by guest on June 11, 2020http://w
ww
.jbc.org/D
ownloaded from
Cyclin A1 Interaction Partners
- 2 -
SUMMARY
The CDK2-associated cyclin A1 is essential for spermatogenesis and contributes
to leukemogenesis. The detailed molecular functions of cyclin A1 remain unclear
since the molecular networks involving cyclin A1/CDK2 have not been
elucidated.
Here, we identified novel cyclin A1/CDK2 interaction partners in a yeast-triple-
hybrid approach. Several novel proteins (INCA1, KARCA1, PROCA1) as well as
the known proteins GPS2, Ku70, RACK1/GNB2L1 and RBM4 were identified as
interaction partners. These proteins link the cyclin A1/CDK2 complex to diverse
cellular processes such as DNA repair, signaling and splicing. Interactions were
confirmed by GST-pulldown assays and co-immunoprecipitation. We cloned and
characterized the most frequently isolated unknown gene which we named
INCA1 (INhibitor of CDK interacting with Cyclin A1). The nuclear INCA1 protein
is evolutionary conserved and lacks homology to any known gene. This novel
protein and two other interacting partners served as substrates for the cyclin
A1/CDK2 kinase complex.
Cyclin A1 and all interaction partners were highly expressed in testis with
varying degrees of tissue-specificity. Highest expression levels were observed at
different time points during testis maturation whereas expression levels in germ
cell cancers and infertile testes decreased.
Taken together, we identified testicular interaction partners of the cyclin
A1/CDK2 complex and studied their expression pattern in normal organs, testis
development and testicular malignancies. Thereby, we establish a new basis for
future functional analyses of cyclin A1. We provide evidence that the cyclin A1-
CDK2 complex plays a role in several signaling pathways important for cell cycle
control and meiosis.
by guest on June 11, 2020http://w
ww
.jbc.org/D
ownloaded from
Cyclin A1 Interaction Partners
- 3 -
INTRODUCTION
Regulation of the cell cycle is one of the most complex features of eukaryotic
cells. Cyclins are regarded as the major regulators of the cell cycle (1-3). Cyclin-
dependent kinases provide the catalytic subunit of the active cyclin/CDK
complex (4-6). Cyclins are involved in the regulation of the mitotic as well as the
meiotic cell cycle (7,8), though the distinct regulatory mechanisms differ (9,10).
Dysregulation of the cell cycle leads to abnormal cell growth and thus
contributes to tumorigenesis (11-14).
Two A-type cyclins are yet known to be involved in cell cycle regulation: cyclin
A1 and cyclin A2. Cyclin A2, also known as cyclin A, is a key regulator of the cell
cycle in mammalian cells. It is ubiquitously expressed and essential for
progression through the cell cycle. Cyclin A2 is involved in both S phase and
G2/M transition through its association with distinct CDKs (15,16). Several lines
of evidence indicate its oncogenic potential (17-19). Cyclin A2 associates with
CDK2 (20) at the onset of DNA replication in S phase (21) and with CDK1 mainly
at the G2/M transition (15).
The second type of human cyclin A (22), named cyclin A1 (in homology to
findings earlier in mouse and Xenopus) associates with CDK2 in vitro and in
vivo, but not with CDK1 in contrast to the interaction of cyclin A1 with CDK1 in
mice. The CDK2/cyclin A1 complex shows kinase activity on histone H1 (22).
Cyclin A1 expression is tissue-specific and high levels of expression are
restricted to testis in the healthy organism in humans (22), to eggs and early
embryos in Xenopus (23) and to the germline in mice (24). Cyclin A1 is
expressed shortly before or during the first meiotic division in spermatogenesis
(25) and male cyclin A1 knockout mice are infertile (26). Spermatogenesis is
arrested prior to entry into metaphase I associated with inactive cyclin B/CDK1
by guest on June 11, 2020http://w
ww
.jbc.org/D
ownloaded from
Cyclin A1 Interaction Partners
- 4 -
complexes and therefore loss of MPF activity (27). Cyclin A1 expression is also
diminished in patients suffering from infertility (28). Cyclin A1 expression
increases at the entry into S phase of previously synchronized leukemic cells
(22). In G2/M phase, cyclin A1 expression and the cyclin A1/CDK2 kinase activity
reach their maximum levels, but cyclin A1 is detectable throughout the cell cycle
in contrast to cyclin A2 (29). It interacts with the cell cycle regulators E2F and
pRb and neutralizes the cell cycle inhibition by pRb in SAOS-2 cells (29), which
indicates a tissue-specific role in mitosis. However, the expression throughout
the cell cycle rules out a major regulatory role for cyclin A1 in the mitotic cell
cycle. The promoter of cyclin A1 is dependent on four Sp1-transactivation sites
in a CpG-island upstream of the transcriptional start site (30).
Cyclin A1 is supposed to play a role in the pathogenesis of myeloid leukemia
since it is highly expressed in leukemias of myeloid origin (31). Upon induction of
myeloid differentiation, cyclin A1 expression decreases (31). Overexpression of
murine cyclin A1 in transgenic mice leads to abnormal myelopoiesis in the first
months after birth as well as to the development of myeloid leukemia at a low
frequency. This indicates that cyclin A1 alone is not sufficient to induce
transformation but contributes to leukemogenesis (32).
The molecular functions of cyclin A1 in pathological and physiological settings
have not been investigated in detail. The distinct functions of cyclin A1 in
mitosis, meiosis and malignant diseases remain currently unknown. In addition,
potential roles of cyclin A1 in other cellular processes have not been
characterized. The major drawback of functional analyses of cyclin A1 on the
molecular level results from the lack of knowledge about interaction partners and
substrates of cyclin A1.
by guest on June 11, 2020http://w
ww
.jbc.org/D
ownloaded from
Cyclin A1 Interaction Partners
- 5 -
The aim of this study was the identification of interaction partners of the cyclin
A1/CDK2 complex in the testis. In a yeast-triple-hybrid approach, we identified
several potential interacting proteins of cyclin A1/CDK2 from a testis cDNA
library. We confirmed the interaction with cyclin A1 by GST pulldown assays and
analyzed the expression of the interaction partners in normal organs, in testis
maturation and in testicular malignancies. We have cloned a novel protein,
INCA1 (INhibitor of CDK interacting with Cyclin A1). INCA1 interacted with cyclin
A1, was phosphorylated by the cyclin A1/CDK2 complex and tissue-specifically
expressed in the testis. In summary, we characterized novel interaction partners
of the cyclin A1/CDK2 complex that will guide the future functional analysis of
cyclin A1.
by guest on June 11, 2020http://w
ww
.jbc.org/D
ownloaded from
Cyclin A1 Interaction Partners
- 6 -
EXPERIMENTAL PROCEDURES
Yeast-Triple-Hybrid-System
To identify cyclin A1-interacting proteins, a yeast-triple-hybrid (Y3H) screen was
performed using the MatchmakerGal4 Two-Hybrid-System 3 (Clontech, Palo
Alto, CA). All experiments were carried out according to the recommendations of
the supplier (Clontech: Yeast Protocols Handbook, Matchmaker Two-Hybrid-
System 3).
In brief, a human testis cDNA library was cloned into the pACT2-AD vector
(Clontech). Cyclin A1 served as bait for the library translation products. Cyclin
A1 and CDK2 were both cloned into pBridge. The plasmids were co-transformed
into the yeast strain AH109 (Clontech). The number of screened clones was
calculated to be 1x107 clones. Transformed yeast cells were grown on high
stringency selection plates (-Met, -Leu, -Trp, -His, -Ade, +XGal). The cDNA
inserts in the positive yeast colonies were amplified by nested PCR. Sequences
were analyzed by alignment to the NCBI databases. For control purposes, we
performed a conventional yeast-two-hybrid (Y2H) screen in parallel with cyclin
A1 as bait but without additional co-expression of human CDK2. This approach
helped to exclude the identification of proteins binding to cyclin A1 only and not
to the active cyclin A1 / CDK2 complex. Only sequences identified in more than
one yeast colony in the Y3H and not present in the Y2H control screen are
presented here and were used for further investigations.
GST fusion proteins & GST pulldown assays
The interaction partners (INCA1 & GPS2: full length cds, all others: longest clone
isolated from the Y3H) were cloned in-frame into the pGEX-5X-2 plasmid
by guest on June 11, 2020http://w
ww
.jbc.org/D
ownloaded from
Cyclin A1 Interaction Partners
- 7 -
(Amersham Pharmacia Biotech, Piscataway, NJ) for expression of GST-fusion
proteins. GST fusion protein was expressed in E. coli BL21-DE3 and purification
was carried out according to the manufacturer's recommendations (GST Gene
Fusion System, Amersham Pharmacia Biotech) using glutathione agarose beads
(Sigma). To control the preparations for equal concentrations and protein
degradation, 10 µl of the slurry were run on an SDS-PAGE gel and stained with
Coomassie Brillant Blue.
For GST-pulldown assays, 1 µg GST protein on glutathione beads was washed
once in 1X binding buffer (50 mM Tris-HCl (pH 7.5), 1.0% NP-40, 400 mM NaCl,
1mM DTT) and resuspended in 100 µl binding buffer in siliconized tubes. 4 µl of
in vitro transcribed and translated cyclin A1, which was radioactively labeled with
[35S]methionine with the TNT QuickCoupled Transcription/Translation System
(Promega, Madison, WI) or lysates of baculovirus-infected Sf9 cells expressing
cyclin A1 were added, and the reaction mix was incubated for one hour at 4°C.
After washing with binding buffer and SDS-PAGE, the gel was dried and
analyzed by autoradiography or western blotting for cyclin A1, respectively.
In vitro kinase reactions
For in vitro kinase assays, GST fusion proteins were incubated with cell lysates
of baculovirus-infected Sf9 cells. 5 µCi [γ-32P]ATP (Perkin Elmer, Boston, MA)
were added to 15 µl of GST fusion beads (50% slurry, equal concentrations
controlled by Coomassie-staining) and 6 µg insect cell lysate, and incubated for
30 minutes in 1X kinase buffer (10 µM ATP, 50 mM Hepes (pH 7.5), 1 mM DTT,
10 mM MgCl2, 0.1 mM Na3VO4, 1 mM NaF). After washing and SDS-PAGE,
phosphorylation of INCA1 was detected by autoradiography. Site-directed
mutagenesis of potential phosphorylation sites to alanine was carried out using
by guest on June 11, 2020http://w
ww
.jbc.org/D
ownloaded from
Cyclin A1 Interaction Partners
- 8 -
Quickchange strategy (Stratagene, La Jolla, CA) following standard protocols
(Primer: Supplementary Table 1).
Real-time quantitative RT-PCR & Northern blot
For expression analysis in normal organs, a commercially available cDNA library
containing pooled human cDNA from various organs was used (Clontech). For
expression analysis in malignant tissues, total RNA was isolated from fresh
frozen tissue samples using TRIzol (Invitrogen, Carlsbad, CA) according to the
manufacturer's recommendations. Twenty µg of total RNA were used for
Northern blot hybridization (31) and probed with the [32P]-labeled cDNA of
human INCA1.
For RT-PCR, 1 µg of total RNA was reverse transcribed using random primers
and MMLV reverse transcriptase (Promega) following the manufacturer's
protocol. cDNA samples were diluted to 100 µl and 2.5 µl of cDNA were used for
each PCR reaction. PCR-amplification of the housekeeping gene
glyceraldehyde-3-phosphate-dehydrogenase (GAPDH) was used to confirm the
quality of cDNA and standardize the total amount of cDNA between different
samples. The quantitation of mRNA expression levels was carried out using a
real-time fluorescence detection method based on TaqMan technology (PE
Biosystems, Foster City, CA) (33,34). All primer and probe combinations (see
Supplementary Table 1) were designed to span an exon-exon junction to avoid
amplification of genomic DNA. The probes were labeled at the 5' end with the
fluorescent dye FAM (cyclin A1, INCA1) or VIC (GAPDH) and at the 3' end with
the quencher TAMRA. For the other interacting clones, specific primer pairs
were designed and the SYBRGreen detection method was used. At least two
independent analyses were performed for each sample. The expression data
by guest on June 11, 2020http://w
ww
.jbc.org/D
ownloaded from
Cyclin A1 Interaction Partners
- 9 -
regarding testis maturation was extracted from published primary microarray
data (35).
Statistical analyses were carried out with SPSS 11.0 for Windows. For
correlation analyses, the non-parametric Kendall Tau correlation analysis was
used. To identify significant differences in gene expression, the non-parametric
Mann-Whitney-U-test and Kruskal-Wallis-test were performed. All P values
indicate two-sided comparisons and P<0.05 was considered as significant.
5’-RACE for INCA1
Transcribed fragments of the genomic clone hRPC.1050_D_4 had been isolated
from six colonies. The encoded gene was cloned by 5’ Rapid Amplification of
cDNA Ends (5'-RACE, Invitrogen). In addition, the murine homolog of INCA1 was
identified by homology searches and 5'-RACE. The GenBank Accession
Numbers for INCA1, KARCA1 and PROCA1 are given in Supplementary Table 2.
For the analysis of the nucleotide and the amino acid sequence of INCA1,
several web-based resources were used. Detailed information about the
software and prediction results are listed in Supplementary Table 3.
The discovered cDNA sequence was PCR-amplified from human testis cDNA
and cloned into different vectors. The vector pcDNA3.1(+) (Invitrogen) was used
as an expression vector in mammalian cells in transfection experiments. In
addition, INCA1 was cloned into pcDNA3.1(+) fused to EGFP (Clontech) or
fused to a Myc-tag. Other vectors and constructs used are described in the
corresponding sections. Where applicable, cyclin A1 was expressed in
pcDNA3.1(+)(33).
by guest on June 11, 2020http://w
ww
.jbc.org/D
ownloaded from
Cyclin A1 Interaction Partners
- 10 -
Promoter activity & Luciferase assay
Following PCR amplification of the sequence upstream of the human INCA1
gene, it was cloned into the pGL3 basic vector in promoter position to the firefly
luciferase gene. Luciferase assays for promoter activity were carried out
essentially as described (30,34) using the Dual-Luciferase Reporter Assay
System (Promega, Madison, WI). Briefly, Cos-7 or S2 cells were transfected with
the promoter constructs in pGL3 vectors and pRL-CMV for standardization
purposes. The promoter activity was determined as the ratio of firefly luciferase
luminescence divided by renilla luciferase activity. All experiments were carried
out independently three times and data are indicated as mean with standard
error.
Cell Culture & Transfection
Cos-7 (simian renal cells transformed by SV40) cells were cultured at 37° C and
5% CO2 in Dulbecco’s Modified Eagle Medium (DMEM, Invitrogen)
supplemented with 10% fetal calf serum (FCS, Biochrom KG, Berlin, Germany),
100 units/ml penicillin and 100 µg/ml streptoMycin (Biochrom), and 2 mM L-
glutamine (Biochrom). ML-1 myeloid leukemia cells were cultured in RPMI with
10% FCS, penicillin and streptomycin at 37°C and 5% CO2. Sf9 insect cells were
cultured at 27° C in Schneider’s insect cell medium (Invitrogen) containing 10%
FCS (Biochrom).
Mammalian cells were transfected using SuperFect (QIAgen, Hilden,
Germany) according to the manufacturer’s protocol. Sf9 Drosophila cells were
infected by baculovirus constructs (Baculovirus Expression Vector System,
PharMingen, San Diego, CA). The cells were lysed on ice in 50 mM Tris-HCl (pH
7.5), 0.5% NP-40, 150 mM NaCl, 1 mM EDTA, and protease inhibitors.
by guest on June 11, 2020http://w
ww
.jbc.org/D
ownloaded from
Cyclin A1 Interaction Partners
- 11 -
For localization analysis of INCA1, EGFP-INCA1 or EGFP alone were
transfected into Cos-7 cells, stained with 1 µg/ml DAPI for DNA and 2.5 µg/ml
TRITC-Phalloidin (both: Sigma) for actin and analyzed by conventional
fluorescence or confocal microscopy.
Antibodies, Co-immunoprecipitation & Western blotting
RIPA lysates (150 mM NaCl, 1.0% NP-40, 0.5% deoxycholic acid, 0.1% SDS,
50 mM Tris-HCl (pH8.0)) with Complete EDTA-free protease inhibitor) or
indicated protein solutions were run on SDS-PAGE gradient gels (Bio-Rad,
Hercules, CA). Subsequently, proteins were electroblotted onto PVDF
membranes Immobilon-P (Millipore, Bedford, MA), stained with specific primary
antibodies and peroxidase-linked secondary antibodies (AffiniPure F(ab’)2
fragment, Jackson ImmunoResearch Laboratories, West Grove, PA) and
detected with ECL plus (Amersham).
Primary antibodies against human INCA1 were raised in rabbits against peptides
aa 26-40 (α-INCA1 #1) and aa 156-170 (α-INCA1 #2) and affinity-purified for the
different peptides. Additional primary antibodies used for immunoprecipitation or
western blot detection were mouse-α-cyclin A1 (B88-2, PharMingen), mouse-α-
c-Myc (9E10, Santa Cruz Biotechnology, Santa Cruz, CA), α-Actin (Sigma),
monoclonal α-EGFP (Clontech).
For co-immunoprecipitation, 500 µl lysate of transfected cells were rotated with 2
µg α-Myc antibody at 4°C for one hour, then 60 µl protein A/G agarose beads
(Santa Cruz Biotechnology) were added, and the reaction mix was rotated at 4°C
again for two hours. After washing with ice-cold RIPA, the bound proteins were
subjected to SDS-PAGE and blotted for EGFP-cyclin A1.
by guest on June 11, 2020http://w
ww
.jbc.org/D
ownloaded from
Cyclin A1 Interaction Partners
- 12 -
For co-immunoprecipitation experiments with endogenous proteins, ML-1 cells,
which highly express cyclin A1 (22), were starved for 24 hours at 0.1% FCS to
induce expression of INCA1 and lysed in NP-40 lysis buffer. A total of 300 µg
protein were precleared with rabbit pre-immune serum and then incubated at
4°C over night with either pre-immune serum or anti-INCA1 serum. Agarose
beads coupled to protein A/G (Santa Cruz) were used for precipitation. Beads
were washed and subjected to SDS-PAGE under non-reducing conditions. The
western blot was then detected with anti-Cyclin A1 antibodies (PharMinGen). A
non-specific band at about 90 kDa was used to demonstrate equal loading of
both samples.
by guest on June 11, 2020http://w
ww
.jbc.org/D
ownloaded from
Cyclin A1 Interaction Partners
- 13 -
RESULTS
Identification of cyclin A1/CDK2 interaction partners
The molecular function of cyclin A1 remains to be elucidated due to a lack of
information about interactions on the molecular level. To identify cyclin A1
interaction partners, we screened a human testis cDNA library for interacting
proteins. A yeast-triple-hybrid-system (Y3H) with CDK2 co-expression was
performed (Fig. 1A). The Y3H should mimic best the physiological conditions of
the active kinase complex of cyclin A1 and CDK2. To minimize the probability of
false positive clones, we only report sequences here that were found at least in
two independent clones. We identified eight sequences for putative cyclin A1
interaction partners in more than one yeast clone: four known genes, two
expressed sequence tags (ESTs) and two unknown cDNAs (Fig. 1B).
Four known genes interacted with the cyclin A1/CDK2 complex
The G-protein Pathway Suppressor 2 (GPS2, Acc# U28963, identical to AMF1)
was identified in four clones. GPS2 has been assigned to different functions in
G-protein, Ras, MAPK and p53 signaling and is part of the nuclear NCOR1-
HDAC3 complex that inhibits JNK activation. We found the nuclear protein Ku70
(Acc# NM_001469) in two clones that binds double-stranded and plays an
essential role in DNA repair. The Guanine Nucleotide Binding protein Beta-2-
Like-1 (GNB2L1, Acc# NM_006098), which is identical to the Receptor for
Activated Protein Kinase C 1 (RACK1), is a homolog of the beta-subunit of
heterotrimeric G proteins. The mRNA-Binding Motif Protein 4 (RBM4, Acc#
NM_002896) is the human homolog to the Drosophila Lark gene that is essential
for embryonic development. Human RBM4 modulates alternative pre-mRNA
by guest on June 11, 2020http://w
ww
.jbc.org/D
ownloaded from
Cyclin A1 Interaction Partners
- 14 -
splicing and antagonizes SR protein function. In two clones, sequences of the
mRNA DKFZ p686G052 (Acc# AL832200, abbreviated here with "DKFZ") were
enclosed. In a database, this sequence was found in 157 ESTs (UniGene
Hs.317304) from several tissues including acute myeloid leukemia. In 69 ESTs
from normal organs, 13 sequences derived from testis. The mRNA encodes a
hypothetical protein of 1686 amino acids (aa) of unknown function.
Identification of three novel proteins interacting with cyclin A1
In six clones, we found fragments of a novel mRNA that was not part of any
human cDNA or EST sequence but was present in a genomic clone (Acc#
AC004771). As this transcript was detected most often in our Y3H assay, we
cloned and characterized it in more detail (see below: Fig. 7 - 9). The sequence
was unknown before and did not contain any homologies or conserved motifs.
Additional functional analyses revealed an inhibitory effect on CDK activity
(Diederichs et al., unpublished). Therefore, we named it "INhibitor of CDK
interacting with Cyclin A1" (INCA1).
In addition, we identified sequences from another mRNA (MGC 33338, Acc#
BC022077) in two Y3H clones. The published mRNA sequence of 1328
nucleotides (nt) contains a small open reading frame (ORF) encoding only 111
aa. In our sequences, we found an insertion of 19 nt in the middle of the
sequence giving rise to a novel ORF coding for 288 aa using a different reading
frame than the hypothetical protein of 111 aa. The larger protein (31 kDa) was in
the same reading frame as the GAL4 activation domain in the pACT2 vector
used for the Y3H assay confirming this new reading frame. The novel full-length
mRNA contains 1347 nt with a coding sequence of 867 nt. The predicted protein
contains amino acid sequences with homologies to two kelch motifs, two ankyrin
by guest on June 11, 2020http://w
ww
.jbc.org/D
ownloaded from
Cyclin A1 Interaction Partners
- 15 -
repeats and a galactose oxidase domain (InterProScan), therefore we named it
"Kelch / Ankyrin Repeat containing Cyclin A1 interacting protein" (KARCA1).
In two other clones, we found a novel mRNA sequence which was only partially
similar to an EST (EST zt86e02, Acc# AA398001). This novel sequence does
not contain a stop codon, but comprises an ORF over its full-length of 399 nt
encoding a protein 133 aa. The gene is located on chromosome 17 and
transcribed from the genomic sequence (Acc# AC010761) in three exons all
adhering to the GT/AG rule for intron start and end sequences. This novel
protein was predicted to be localized in the nucleus and contained a proline-rich
region from residues aa 4 to aa 60 that could be involved in protein-protein
interaction. We assume that we identified a partial coding sequence of a novel
protein that we called "PROline-rich Cyclin A1 interacting protein" (PROCA1).
A novel gene: "INhibitor of CDK interacting with Cyclin A1" (INCA1)
encoded a 221 aa protein and localized to chromosome 17
We identified different fragments of one cDNA in six yeast clones. The
sequences corresponded to a genomic clone (clone hRPC.1050_D_4, GenBank
Acc# AC004771.1). This gene was not described before and did not exhibit any
homologies to other known genes (see below). Due to further functional
experiments (Diederichs et al., unpublished), we named it "INhibitor of CDK
interacting with Cyclin A1" (INCA1). We performed 5'-RACE (Rapid Amplification
of cDNA Ends) with the unknown cDNA sequence of INCA1 and isolated a
mRNA sequence of 1383 nucleotides (nt) including an open reading frame
(ORF) of 221 amino acids (aa) (Fig. 2A). Human INCA1 consisted of eight exons
with the coding sequence located from exons three to eight. The second exon
was alternatively spliced leading to an mRNA of only 1221 nt which did not alter
by guest on June 11, 2020http://w
ww
.jbc.org/D
ownloaded from
Cyclin A1 Interaction Partners
- 16 -
the ORF. We also identified the murine homolog of INCA1. Murine INCA1
(mINCA1) included seven exons with 1218 nt. The coding sequence was located
from exons two to seven and encoded a protein sequence of 231 aa. The first
murine exon could be alternatively spliced giving rise to four splice variants of
1080 nt, 1150 nt, 1189 nt and 1218 nt, which all encode the same protein.
Human INCA1 localized to chromosome 17p13, the murine homolog mapped to
chromosome 11B. The primary nucleotide and amino acid sequences of human
and murine INCA1 were analyzed with several web-based bioinformatic tools
(Supplementary Table 3). For the human INCA1 protein, a molecular weight of
the unmodified protein of 25.2 kDa was predicted, for the murine homolog
26.5 kDa. The human and the murine INCA1 coding sequences showed 70.8%
homology on the nucleotide and 57.4% identity on the amino acid level. The
localization of both proteins was predicted to be nuclear. Both sequences
contained multiple consensus sites for phosphorylation and other
posttranslational modifications. Upstream of the human INCA1 gene, we found a
functional promoter sequence for INCA1 (compare Fig. 7).
The nucleotide and amino acid sequences of the three novel proteins INCA1,
KARCA1 and PROCA1 are presented in Fig. 2 and have been deposited into
GenBank (Accession Numbers in Supplementary Table 2).
Interaction with cyclin A1 and phosphorylation by the cyclin A1/CDK2
complex
The eight putative interacting proteins and their fragments isolated in the Y3H
are given in figure 3A. All of these proteins contained several SP or TP motifs,
which provides the minimal consensus motif for CDK phosphorylation, and four
by guest on June 11, 2020http://w
ww
.jbc.org/D
ownloaded from
Cyclin A1 Interaction Partners
- 17 -
of them contained the full consensus motif for CDK phosphorylation
(S/T)PX(K/R) (Fig. 3A).
The interaction with cyclin A1 was confirmed for all eight proteins in vitro by GST
pulldown assays. Recombinant radioactively-labeled cyclin A1 was incubated
with GST fusion proteins of the interaction partners. Cyclin A1 was not pulled
down with GST alone, but with all other GST fusion proteins (Fig. 3B).
The analysis of the interaction with cyclin A1 was hindered by the lack of
available antibodies for the interacting proteins. We cloned mammalian
expression vectors for three interaction partners (INCA1, GPS2, Ku70) and
confirmed also the interaction in vivo for these. In co-immunoprecipitation
assays, antibodies against Myc-tagged interaction partners INCA1, GPS2 and
Ku70 also precipitated cyclin A1, whereas unspecific IgG or Myc alone did not
(GPS2: Fig. 3C). The interaction with INCA1 was studied in more detail and is
presented in Fig. 10. The interaction with Ku70 was further analyzed and will be
published elsewhere (Müller-Tidow et al., manuscript submitted).
To examine whether the cyclin A1/CDK2 complex could phosphorylate its
interaction partners, we carried out in vitro kinase assays with the GST fusion
proteins. The fusion protein or GST alone bound to glutathione agarose beads
were incubated in the presence of [γ-32P]ATP with lysates of baculovirus-infected
Sf9 insect cells expressing either cyclin A1 and CDK2 together (Fig. 3D) or
cyclin A1 or CDK2 alone (Fig. 3E). GST alone was not phosphorylated by cyclin
A1/CDK2. Cyclin A1/CDK2 phosphorylated INCA1, Ku70 and RBM4 (Fig. 3D).
This phosphorylation was specific for the cyclin A1/CDK2 complex as it was not
seen for cyclin A1 or CDK2 alone (Fig. 3E). For RACK1/GNB2L1, a faint band
was observed in some experiments, but was not considered significant.
by guest on June 11, 2020http://w
ww
.jbc.org/D
ownloaded from
Cyclin A1 Interaction Partners
- 18 -
Cyclin A1 interaction partners are expressed in the testis
So far, the main identified cellular function of cyclin A1 is its involvement in
meiosis (26). In normal organs, cyclin A1 is tissue-specifically expressed in the
testis ((22) & Fig. 4A).
The expression patterns of cyclin A1 and its interaction partners were analyzed
in a panel of sixteen normal organs by real-time quantitative RT-PCR (Fig. 4B).
The amount of cDNA in each sample was standardized using the expression
level of the housekeeping gene GAPDH. Gene expression was normalized to the
expression in testis (testis expression = 1) for each gene.
All genes showed high expression levels in the testis. Some genes (Cyclin A1:
4A, INCA1: 4B, PROCA1: 4I) were almost exclusively expressed in the testis
with low levels of expression in other organs, e.g. in the ovary. Other genes
(GPS2: 4C, Ku70: 4D, RBM4: 4F, DKFZ: 4G, KARCA1: 4H) were highly
expressed in the testis and also showed high expression levels in some other
organs. Only one gene (RACK1/GNB2L1: 4E) was expressed at an intermediate
level in the testis and higher in eight other organs. The predominant expression
in the testis is obvious in a logarithmic bar graph standardized to the testicular
expression levels (Fig. 4J) in which all genes including cyclin A1 demonstrate
lower expression (below x-axis) in other organs than in testis except
RACK1/GNB2L1.
Cyclin A1 and its interaction partners are regulated during testis
maturation and spermatogenesis
Recently, a microarray study analyzing gene regulation throughout post-natal
testis development has been published (35) and the expression data are
available through the world wide web. Murine homologs of cyclin A1 and seven
by guest on June 11, 2020http://w
ww
.jbc.org/D
ownloaded from
Cyclin A1 Interaction Partners
- 19 -
of the eight interacting proteins were included in the oligonucleotide microarray.
Our novel mRNA PROCA1 was not found on the array. We extracted primary
microarray data for the other genes of interest. The expression data were
normalized to the maximal expression of each gene to facilitate the direct
comparison of expression regulation throughout testis development for different
genes (Fig. 5A).
Cyclin A1 was strongly induced in the maturing testis with highest expression
from day 26 to the adult stage. Though not all other genes reached their maximal
expression level at this stage, they all were substantially expressed in adult
testis corroborating their potential functional interaction in the testis.
RACK1/GNB2L1, RBM4 and Ku70 decreased, whereas DKFZ, INCA1, GPS2
and KARCA1 expression levels increased during testis maturation. GPS2 and
KARCA1 showed an expression pattern identical to the cyclin A1 expression
pattern.
In the microarray studies, we detected earlier expression of INCA1 in the testis
than expression of cyclin A1. This finding was confirmed by expression studies
in ATM-/- mice which have a meiotic block at prophase I (36). These mice still
express INCA1 in the testis but do not express cyclin A1 anymore (Bäumer N &
Müller-Tidow C, unpublished).
Decreased expression of cyclin A1 interacting proteins in testis tumors and
infertile tissue
In testis samples from patients suffering from infertility, cyclin A1 expression was
lost in germ cell aplasia and its expression increased with progression of
spermatogenesis (28). We studied the expression levels of cyclin A1 and its
interaction partners in normal testis (n=6) and in biopsies from infertile patients
by guest on June 11, 2020http://w
ww
.jbc.org/D
ownloaded from
Cyclin A1 Interaction Partners
- 20 -
(n=35) with histologically different stages of maturation arrest. Compared to
normal testis, the average expression of all analyzed genes was two- to fourfold
decreased in the infertility testis samples (Fig. 5B). The differences between
normal and infertile testis were significant for cyclin A1, GPS2, Ku70,
RACK1/GNB2L1, RBM4 and KARCA1. Expression levels of all genes except
RACK1/GNB2L1 significantly correlated with the expression of cyclin A1.
Cyclin A1 was expressed in aggressive germ cell tumors, e.g. immature
teratoma or embryonal cell carcinoma, whereas its expression was lost in more
differentiated tumor types as mature teratoma (37). We analyzed the expression
of cyclin A1 and its interaction partners in normal testis (n=7) and in testis
tumors (n=29). Cyclin A1 expression was decreased in malignant testis tissue
compared to normal testis. Concurrently, expression of INCA1, GPS2, Ku70,
RBM4, DKFZ, KARCA1 and PROCA1 was significantly reduced (Fig. 6A). Only
RACK1 was higher expressed in testis tumors than in normal testis. In
correlation analysis including all patient samples, the expression levels of cyclin
A1 correlated significantly (P<0.05) with the expression levels of GPS2, Ku70,
RBM4, DKFZ and PROCA1. We differentiated the testis tumor samples into
histological subgroups (Fig. 6B-J; embryonal carcinoma (EC, n=6), immature
teratoma (iT, n=4), yolc-sac tumor (YS, n=3), seminoma (S, n=7), mature
teratoma (mT, n=6)). Three tumor samples were excluded from this analysis due
to an unclear histological classification. In Kruskal-Wallis analysis, the
expression levels of cyclin A1, INCA1, GPS2, Ku70, RBM4 and KARCA1 differed
significantly between the histological subtypes.
by guest on June 11, 2020http://w
ww
.jbc.org/D
ownloaded from
Cyclin A1 Interaction Partners
- 21 -
INCA1 interacted with cyclin A1 in vitro and in vivo
Following the identification of INCA1 as a novel protein, we confirmed the
interaction between cyclin A1 and INCA1. To analyze the interaction in vitro,
GST pulldown assays with cell lysates or in vitro synthesized cyclin A1 were
performed. INCA1 was cloned as a GST-fusion protein, expressed in E. coli and
purified using glutathione agarose beads. Cyclin A1 was either pulled down from
lysates of baculovirus-infected Sf9 cells or transcribed and translated in vitro and
labeled with [35S]methionine. In GST pulldown assays, cyclin A1 interacted with
GST-INCA1, but not with GST alone, indicating a specific interaction between
cyclin A1 and INCA1 in vitro (Fig. 7A).
For analysis in vivo, Cos-7 cells were transfected with expression plasmids for
EGFP-cyclin A1 and Myc-INCA1. INCA1 was immunoprecipitated from whole cell
lysates with α-Myc antibodies. The subsequent western blot for EGFP-cyclin A1
demonstrated the specific interaction of INCA1 and cyclin A1 in vivo by their co-
immunoprecipitation. Cyclin A1 was not precipitated from the cell lysate by non-
specific antibodies (Fig. 7B). In addition, we confirmed interaction of endogenous
cyclin A1 and INCA1 in vivo. ML-1 myeloid leukemia cells express high levels of
cyclin A1 (22). Starvation of these cells led to induction of INCA1 (data not
shown). In protein lysates of these cells, we found in vivo interaction of
endogenous cyclin A1 and endogenous INCA1 by co-immunoprecipitation.
Cyclin A1 was not pulled down by pre-immune serum but specifically with
immune sera against INCA1 (Fig. 7B).
by guest on June 11, 2020http://w
ww
.jbc.org/D
ownloaded from
Cyclin A1 Interaction Partners
- 22 -
Cyclin A1 and cyclin A2 in complex with CDK2 phosphorylated INCA1 in
vitro predominantly at Ser176
INCA1 interacted in vitro and in vivo with cyclin A1 and was found in the yeast-
triple-hybrid screen for interacting partners of cyclin A1 in complex with CDK2.
These findings and consensus sequences for potential phosphorylation by
cyclin-dependent kinases in the INCA1 sequence led us to the hypothesis, that
INCA1 was phosphorylated by the cyclin A1/CDK2 complex (Fig. 3D+E). To
examine whether the cyclin A2/CDK2 complex also could phosphorylate INCA1,
we carried out in vitro kinase assays with the fusion protein GST-INCA1. Indeed,
GST-INCA1 was strongly phosphorylated by the cyclin A1/CDK2 or by the cyclin
A2/CDK2 complex, but not by either protein alone (Fig. 7C).
Cloning and analysis of different INCA1 fragments indicated strong
phosphorylation of the C-terminus (aa 149-221) (Fig. 7D). The N-terminus (aa 1-
74) was weakly phosphorylated by cyclin A1/CDK2, whereas the intermediate
fragment was also phosphorylated by CDK2 alone (data not shown).
Human and murine INCA1 contain four potential phosphorylation sites that were
conserved between species: T167PGR matched exactly the consensus site for
CDK phosphorylation, whereas S23P, S176P and S179P only showed a conserved
SP motif necessary for CDK phosphorylation in both species. Site-directed
mutagenesis of the potential phosphorylation sites to non-phosphorylatable
alanine uncovered predominant phosphorylation of S23 in the N-terminus and
S176 and T167 in the C-terminus. For a double-mutant including T167A and S176A,
the strong phosphorylation of the C-terminus was diminished (Fig. 7E).
by guest on June 11, 2020http://w
ww
.jbc.org/D
ownloaded from
Cyclin A1 Interaction Partners
- 23 -
INCA1 mRNA and protein were expressed in vivo
Since INCA1 was the interaction partner identified most often in our Y3H assay,
we studied this novel gene in greater detail. To determine whether the INCA1
gene was transcribed and translated in vivo, we performed Northern blot
analysis with total RNA from different organs of two monkey species (Macaca
fascicularis (M.f.), Callithrix jacchus (C.j.)), Homo sapiens (H.s.) and Mus
musculus (M.m.) (Fig. 8A). High expression of INCA1 mRNA was detected in
monkey and human testis. In murine testis, only a faint signal was seen, most
probably because of the human INCA1 probe used. The two bands for INCA1 in
monkey and human correspond to the two splice variants with 1.4 kb and 1.2 kb,
respectively.
To detect protein expression levels, we raised antibodies against two peptides of
human INCA1 and affinity-purified them using the epitopes aa 26-40 (α-
INCA1#1) or aa 156-170 (α-INCA1#2) (Fig. 8B-C). Transfection of the INCA1
coding sequence into insect and mammalian cell lines led to expression of
INCA1 protein (Fig. 8B). In Sf9 insect cells, the antibodies raised against
hINCA1 detected a band at an apparent molecular weight of approx. 28 kDa
(shown here for α-INCA1#1). This probably represented a posttranslationally
less modified protein and was closer to the predicted weight of 25.2 kDa. In
mammalian Cos-7 cells, the apparent molecular weight was approx. 36 kDa. By
bioinformatic sequence analysis, several putative consensus sites for
posttranslational modifications were detected, e.g. serine glycosylation or
tyrosine sulfation. Various putative phosphorylation sites for different kinases
existed in the INCA1 sequence. These included consensus sites for CDK
phosphorylation (see Fig. 8C & Supplementary Table 3).
by guest on June 11, 2020http://w
ww
.jbc.org/D
ownloaded from
Cyclin A1 Interaction Partners
- 24 -
Western blot analysis of different human cell lines revealed low levels of INCA1
protein expression in HeLa, KCL22 and NB4. In the leukemic cell lines U937 and
ML-1, no INCA1 expression was observed. Both α-INCA1 antibodies detected
the INCA1 band at the same size in human cell lines and in INCA1-transfected
Cos-7 cells. In HeLa cells, a smaller band appeared on the Western blot, which
was not detectable with the second α-INCA1 antibody and therefore was
considered unspecific.
INCA1 localized to the nucleus
The INCA1 sequence was analyzed for intracellular localization signals. INCA1
did not show any transmembrane domains or docking sites for a GPI anchor,
suggesting that it was not membrane-bound. A signal sequence for nuclear
localization (NLS: RRKKRR = aa 75-80) was found within the INCA1 sequence.
To analyze the localization of INCA1 in vivo, we cloned a fusion protein of INCA1
and the enhanced green fluorescent protein (EGFP). EGFP-INCA1 was
expressed in Cos-7 cells and its localization was analyzed by conventional
fluorescence microscopy (Fig. 8D a+b) and confocal laser scanning microscopy
(Fig. 8D c+d). In addition, cells were stained with DAPI for DNA in the nucleus
and TRITC-Phalloidin for Actin in the cytoplasm. EGFP alone, used as negative
control, led to staining throughout the cell with predominance in the cytoplasm
(Fig. 8D a+c). EGFP-INCA1 exclusively localized to the nucleus of the cells (Fig.
8D b+d). Merging of EGFP and DAPI fluorescence demonstrated the differential
localization of EGFP and EGFP-INCA1. Confocal microscopy revealed a non-
homogenous granular staining pattern in the nucleus (Fig. 8D d).
by guest on June 11, 2020http://w
ww
.jbc.org/D
ownloaded from
Cyclin A1 Interaction Partners
- 25 -
The expression of INCA1 is regulated by a Sp1-dependent promoter
To further analyze the genomic structure and transcriptional regulation of
hINCA1, we cloned the genomic sequence upstream of the transcriptional start
site of hINCA1. We found a fragment of 1620 base pairs reaching from -1523 to
+97 actively driving transcription in a luciferase assay (Fig. 9A). In Cos-7 cells,
promoter fragments of 1620 bp or 593 bp increased luciferase activity more than
50-fold compared to the empty pGL3 basic vector. The putative promoter
sequence contained several consensus sequences for binding sites of the
transcription factor Sp1. We therefore tested its promoter activity in S2 insect
cells lacking endogenous Sp1. In S2 cells without Sp1, no promoter activity was
detected, whereas coexpression of Sp1 strongly increased INCA1 promoter
activity (Fig. 9B). Fragmentation of the INCA1 promoter revealed high promoter
activities for fragments containing the sequence -254 / +97, that was
substantially decreased, when further sequences either on the 5` or on the 3`
site were deleted (Fig. 9C). In addition, we tested the INCA1 promoter response
to Trichostatin A (TSA) or 5-aza-Cytidine (Aza) in HeLa cells by analyzing the
INCA1 mRNA expression. The Histone-Deacetylase-Inhibitor TSA strongly
induced the mRNA expression of INCA1, whereas the inhibition of promoter
methylation alone by Aza did not significantly increase the INCA1 expression
level (Fig. 9D). These data indicate that the genomic sequence upstream of the
human INCA1 gene contained a functional promoter that was dependent on Sp1
and repressed by histone deacetylase activity.
by guest on June 11, 2020http://w
ww
.jbc.org/D
ownloaded from
Cyclin A1 Interaction Partners
- 26 -
DISCUSSION
Cyclin A1 is essential for spermatogenesis (26) and possesses oncogenic
properties in the hematopoietic system (32). It is highly expressed in testis (22)
and in myeloid leukemia (31). Despite some progress in recent years (27,29,38),
its molecular and cellular function in either environment has not been
characterized in detail due to a lack of knowledge about interaction partners and
substrates of the cyclin A1/CDK2 heterodimer. A coherent view on its role in
spermatogenesis as well as in leukemogenesis is still missing.
In this study, we used a yeast-triple-hybrid approach to identify interaction
partners of the cyclin A1/CDK2 complex in a testis cDNA library. The interaction
was verified for all isolated proteins in GST pulldown assays. In in vitro kinase
assays with cyclin A1/CDK2, phosphorylation of INCA1, Ku70 and RBM4
indicated their role as substrate of the cyclin A1/CDK2 complex. The other
identified proteins might be phosphorylated only under in vivo conditions or are
interaction partners of the complex that are not phosphorylated.
Analysis of mRNA expression revealed a close correlation of cyclin A1
expression and its interaction partners in normal organs and in samples from
normal, malignant and infertile testis. In general, this pattern of co-expression
increases the likelihood of functionally important interactions between cyclin A1
and its co-regulated new interactors in vivo. The interacting proteins included
five previously described proteins (GPS2, Ku70, RACK1/GNB2L1, RBM4 and the
mRNA DKFZ p686G052) as well as three novel proteins (INCA1, KARCA1,
PROCA1).
by guest on June 11, 2020http://w
ww
.jbc.org/D
ownloaded from
Cyclin A1 Interaction Partners
- 27 -
The interaction of cyclin A1 with known proteins hints to new functions
GPS2 suppresses growth and controls intracellular signaling via inhibition of the
Ras - MAPK - JNK pathway (39,40), modulates p53 transactivation (41),
interacts with viral proteins and is an integral subunit of the N-Cor - HDAC3 -
corepressor complex (42,43). GPS2 is a nuclear protein, a fact which fits well
with the localization of cyclin A1 in testis, and its expression pattern in normal
organs, testis maturation and malignant and infertile testis correlates well with
cyclin A1 expression patterns. Therefore, the interaction of GPS2 and cyclin
A1/CDK2 in testis is likely to be physiologically relevant and will be a prime
candidate for further investigations.
Ku70 is essential for DNA repair of double strand breaks by non-homologous
end joining (NHEJ) (44) and thereby contributes to genomic stability (45). It is
currently believed to function as a switch between NHEJ repair and homologous
recombination (46). It heterodimerizes with Ku86 to form a DNA helicase and
binds to and unwinds double stranded DNA ends (47). Its role in V(D)J
recombination (48) is well established. The expression and function of Ku70 in
testis has been a matter of debate: substantial age-dependent expression of
Ku70 in testis has been documented (49) as well as its absence in earliest
stages of meiosis (prophase I) (50). However, we isolated the Ku70 cDNA in our
Y3H assay from a testis cDNA library indicating expression in testis. In addition,
we found expression of Ku70 in normal testis in our samples by real-time
quantitative RT-PCR (Fig. 4) and Ku70 expression was also detected on the
microarrays of maturing testis (Fig. 5). Besides, cyclin A1 is expressed in other
organs than testis on intermediate levels as we report here (Fig. 4); therefore,
the interaction with Ku70 might also be important in other processes than
spermatogenesis. Other proteins involved in DNA repair are essential for
by guest on June 11, 2020http://w
ww
.jbc.org/D
ownloaded from
Cyclin A1 Interaction Partners
- 28 -
spermatogenesis, increasing the likelihood of a physiological role of Ku70 in the
testis (51). However, we provide evidence for the first time for an involvement of
a cyclin/CDK complex in Ku70-mediated DNA repair. In fact, we were able to link
cyclin A1 to DNA repair mediated by Ku70 and regulation by p53 after irradiation
(Müller-Tidow et al., manuscript submitted)
The RACK1/GNB2L1 protein is a receptor for activated protein kinase C and a
homolog of the beta subunit of heterotrimeric G proteins (52,53). RACK1 is a
substrate (54) and an inhibitor of the Src tyrosine kinase leading to growth
inhibition (55). RACK1 is detectable in the cytoplasm interacting with the
interferon receptor (56). RACK1 also binds to the p53-homolog p73 and to pRb,
which both localize to the nucleus (57); therefore, at least a fraction of RACK1
must be nuclear. In addition, pRb is also a substrate for the cyclin A1/CDK2
complex (29) suggesting a possible complex including pRb, cyclin A1 and
RACK1. However, as cyclin A1 is localized to the cytoplasm in myelopoiesis
(32), a functional interaction with RACK1 in this compartment is also possible.
The nuclear protein RBM4 is the human homolog to the Drosophila gene Lark
which is essential for embryonic development (58). RBM4 binds to mRNA and is
involved in the regulation of alternative splicing (59). Other RBM proteins are
connected to spermatogenesis (60). RBM4 not only binds to cyclin A1, it is also
in vitro phosphorylated by the cyclin A1/CDK2 complex. Hereby, we provide the
first link of cyclin A1 to splicing, whereas other cyclins have already been linked
to the splicing machinery (61,62), especially cyclin E (63) which associates with
CDK2 similar to cyclin A1.
We also found the hypothetical protein DKFZ p686G052 as a novel cyclin A1
interacting partner. Its sequence was found in several ESTs isolated e.g. from
testis or from AML samples indicating an overlapping expression pattern with
by guest on June 11, 2020http://w
ww
.jbc.org/D
ownloaded from
Cyclin A1 Interaction Partners
- 29 -
cyclin A1. In our expression analyses, we confirmed considerable expression of
this mRNA in testis and in other organs and we found significant induction during
testis development.
Taken together, expression studies in normal organs revealed substantial
expression of all interacting proteins in the testis. The induction of four of the
seven analyzed identified interaction partners during testis maturation and the
expression of all of them in the adult testis hints at their potential involvement in
meiosis or spermatogenesis which will be subject to further investigations.
Three novel proteins will provide new insights into cyclin A1 biology
In addition, we isolated three novel proteins interacting with the cyclin A1/CDK2
complex. Following the properties of the novel amino acid sequences, we named
these proteins "INCA1", "KARCA1" and "PROCA1". INCA1 and PROCA1 were
predicted to localize to the nucleus and all three new genes were significantly
expressed in the testis. The temporal expression profile of KARCA1 during testis
development was identical to cyclin A1, indicating its potential involvement in
meiosis and emphasizing the functional interaction with the active cyclin
A1/CDK2 complex. For KARCA1, we provide the full-length mRNA sequence,
whereas the PROCA1 sequence probably represents only a partial coding
sequence. KARCA1 contains two kelch motifs and two ankyrin repeats. Kelch
motifs were first identified in Drosophila egg chamber regulatory proteins and
were assigned to diverse functions including galactose oxidation (galactose
oxidase), sialic acid hydrolysis (neuraminidase) or actin cross-linking (scruin).
Ankyrin repeats belong to the most common protein-protein interaction motifs.
The usually tandemly repeated helix-loop-helix structures are also found twice in
KARCA1. This repeat was also found in proteins with a broad range of functions
by guest on June 11, 2020http://w
ww
.jbc.org/D
ownloaded from
Cyclin A1 Interaction Partners
- 30 -
reaching from transcriptional regulation, cell cycle control, cytoskeleton, ion
transport to signal transduction (e.g. Notch, p53 binding proteins and EGF-like
domains contain Ankyrin repeats). Therefore, the presence of neither the kelch
nor the ankyrin motifs directly hints to a specific function but opens several
opportunities for protein-protein interaction. Future functional studies will
uncover the role of these proteins in physiological and pathological settings.
INCA1 was the interacting sequence isolated most often in our Y3H approach
that we subsequently cloned and characterized. In the genomic sequences
upstream of the INCA1 gene, we identified a functional promoter corroborating
the identification of the full-length transcript and an intact genomic locus of
INCA1. This promoter was dependent on the transcription factor Sp1, which also
regulates the cyclin A1 promoter. In vitro, INCA1 was phosphorylated by cyclin
A1 or cyclin A2 in complex with CDK2, but at least in testis, the tissue-specific
expression pattern of cyclin A1 and INCA1 might indicate that cyclin A1 is
physiologically the more relevant interacting partner. The nuclear localization of
INCA1 reveals identical subcellular compartimentation of the active cyclin
A1/CDK2 complex and its substrate INCA1. In healthy tissue, INCA1 expression
was highest in testis, followed by intermediate expression levels in ovary,
pancreas, lung, liver and spleen. Therefore, expression patterns of cyclin A1 and
INCA1 correlated well with regard to the testis, whereas expression in other
organs was not closely correlated. The induction of INCA1 in testis maturation
hints at a potential role in spermatogenesis. Since INCA1 was the predominant
cyclin A1/CDK2-interacting protein identified in our studies, its functional
characterization will shed light on the molecular mechanisms underlying cyclin-
regulated meiosis and spermatogenesis. First functional analyses indicate a
by guest on June 11, 2020http://w
ww
.jbc.org/D
ownloaded from
Cyclin A1 Interaction Partners
- 31 -
growth-suppressive function through regulation of CDK activity by INCA1
(Diederichs et al., unpublished).
In summary, we identified eight interaction partners of the cyclin A1/CDK2
complex including three novel proteins and studied their expression pattern in
several organs and developing, adult normal, malignant and infertile testis. Our
analyses will guide future functional studies to unravel the molecular functions of
cyclin A1 in physiological and pathological settings and thereby establish a basis
for further investigations.
by guest on June 11, 2020http://w
ww
.jbc.org/D
ownloaded from
Cyclin A1 Interaction Partners
- 32 -
ACKNOWLEDGEMENTS
We thank Maria Möller, Sarah Pierschalski and Barbara Mlody for excellent
technical assistance and Peijun Zuo for help with the initial identification of
INCA1. This research is supported by grants from the Deutsche Krebshilfe (10-
1539-Mü2), the Deutsche José-Carreras-Leukämie-Stiftung and the Deutsche
Forschungsgemeinschaft (Mu1328/2-3).
by guest on June 11, 2020http://w
ww
.jbc.org/D
ownloaded from
Cyclin A1 Interaction Partners
- 33 -
REFERENCES
1. Evans, T., Rosenthal, E. T., Youngblom, J., Distel, D., and Hunt, T. (1983)
Cell 33, 389-396.
2. Murray, A. W., Solomon, M. J., and Kirschner, M. W. (1989) Nature 339,
280-286.
3. Pines, J. (1993) Trends Biochem Sci 18, 195-197.
4. van den Heuvel, S., and Harlow, E. (1993) Science 262, 2050-2054.
5. Nigg, E. A. (1995) Bioessays 17, 471-480.
6. Pines, J. (1999) Nat Cell Biol 1, E73-79.
7. Westendorf, J. M., Swenson, K. I., and Ruderman, J. V. (1989) J Cell Biol
108, 1431-1444
8. Kishimoto, T. (2003) Curr Opin Cell Biol 15, 654-663
9. Forsburg, S. L., and Hodson, J. A. (2000) Nat Genet 25, 263-268
10. Ortega, S., Prieto, I., Odajima, J., Martin, A., Dubus, P., Sotillo, R.,
Barbero, J. L., Malumbres, M., and Barbacid, M. (2003) Nat Genet 35, 25-
31
11. Hartwell, L. H., and Kastan, M. B. (1994) Science 266, 1821-1828.
12. Hanahan, D., and Weinberg, R. A. (2000) Cell 100, 57-70.
13. Sherr, C. J. (2000) Cancer Res 60, 3689-3695.
14. Evan, G. I., and Vousden, K. H. (2001) Nature 411, 342-348.
15. Pagano, M., Pepperkok, R., Verde, F., Ansorge, W., and Draetta, G.
(1992) EMBO J 11, 961-971.
16. Morgan, D. O. (1995) Nature 374, 131-134.
17. Guadagno, T. M., Ohtsubo, M., Roberts, J. M., and Assoian, R. K. (1993)
Science 262, 1572-1575.
by guest on June 11, 2020http://w
ww
.jbc.org/D
ownloaded from
Cyclin A1 Interaction Partners
- 34 -
18. Barrett, J. F., Lewis, B. C., Hoang, A. T., Alvarez, R. J., Jr., and Dang, C.
V. (1995) J Biol Chem 270, 15923-15925.
19. Desdouets, C., Sobczak-Thepot, J., Murphy, M., and Brechot, C. (1995)
Prog Cell Cycle Res 1, 115-123
20. Tsai, L. H., Harlow, E., and Meyerson, M. (1991) Nature 353, 174-177
21. Tsai, L. H., Lees, E., Faha, B., Harlow, E., and Riabowol, K. (1993)
Oncogene 8, 1593-1602
22. Yang, R., Morosetti, R., and Koeffler, H. P. (1997) Cancer Res 57, 913-
920.
23. Howe, J. A., Howell, M., Hunt, T., and Newport, J. W. (1995) Genes Dev
9, 1164-1176.
24. Sweeney, C., Murphy, M., Kubelka, M., Ravnik, S. E., Hawkins, C. F.,
Wolgemuth, D. J., and Carrington, M. (1996) Development 122, 53-64.
25. Ravnik, S. E., and Wolgemuth, D. J. (1999) Dev Biol 207, 408-418.
26. Liu, D., Matzuk, M. M., Sung, W. K., Guo, Q., Wang, P., and Wolgemuth,
D. J. (1998) Nat Genet 20, 377-380.
27. Liu, D., Liao, C., and Wolgemuth, D. J. (2000) Dev Biol 224, 388-400.
28. Schrader, M., Müller-Tidow, C., Ravnik, S., Müller, M., Schulze, W.,
Diederichs, S., Serve, H., and Miller, K. (2002) Hum Reprod 17, 2338-
2343.
29. Yang, R., Müller, C., Huynh, V., Fung, Y. K., Yee, A. S., and Koeffler, H.
P. (1999) Mol Cell Biol 19, 2400-2407.
30. Müller, C., Yang, R., Beck-von-Peccoz, L., Idos, G., Verbeek, W., and
Koeffler, H. P. (1999) J Biol Chem 274, 11220-11228.
by guest on June 11, 2020http://w
ww
.jbc.org/D
ownloaded from
Cyclin A1 Interaction Partners
- 35 -
31. Yang, R., Nakamaki, T., Lübbert, M., Said, J., Sakashita, A.,
Freyaldenhoven, B. S., Spira, S., Huynh, V., Müller, C., and Koeffler, H. P.
(1999) Blood 93, 2067-2074.
32. Liao, C., Wang, X. Y., Wei, H. Q., Li, S. Q., Merghoub, T., Pandolfi, P. P.,
and Wolgemuth, D. J. (2001) Proc Natl Acad Sci U S A 98, 6853-6858.
33. Müller, C., Readhead, C., Diederichs, S., Idos, G., Yang, R., Tidow, N.,
Serve, H., Berdel, W. E., and Koeffler, H. P. (2000) Mol Cell Biol 20, 3316-
3329.
34. Linggi, B., Müller-Tidow, C., van de Locht, L., Hu, M., Nip, J., Serve, H.,
Berdel, W. E., van der Reijden, B., Quelle, D. E., Rowley, J. D.,
Cleveland, J., Jansen, J. H., Pandolfi, P. P., and Hiebert, S. W. (2002) Nat
Med 8, 743-750
35. Schultz, N., Hamra, F. K., and Garbers, D. L. (2003) Proc Natl Acad Sci U
S A 100, 12201-12206
36. Xu, Y., Ashley, T., Brainerd, E. E., Bronson, R. T., Meyn, M. S., and
Baltimore, D. (1996) Genes Dev 10, 2411-2422
37. Müller-Tidow, C., Diederichs, S., Schrader, M. G., Vogt, U., Miller, K.,
Berdel, W. E., and Serve, H. (2003) Cancer Lett 190, 89-95
38. Müller-Tidow, C., Wang, W., Idos, G. E., Diederichs, S., Yang, R.,
Readhead, C., Berdel, W. E., Serve, H., Saville, M., Watson, R., and
Koeffler, H. P. (2001) Blood 97, 2091-2097.
39. Spain, B. H., Bowdish, K. S., Pacal, A. R., Staub, S. F., Koo, D., Chang,
C. Y., Xie, W., and Colicelli, J. (1996) Mol Cell Biol 16, 6698-6706
40. Jin, D. Y., Teramoto, H., Giam, C. Z., Chun, R. F., Gutkind, J. S., and
Jeang, K. T. (1997) J Biol Chem 272, 25816-25823.
by guest on June 11, 2020http://w
ww
.jbc.org/D
ownloaded from
Cyclin A1 Interaction Partners
- 36 -
41. Peng, Y. C., Kuo, F., Breiding, D. E., Wang, Y. F., Mansur, C. P., and
Androphy, E. J. (2001) Mol Cell Biol 21, 5913-5924.
42. Peng, Y. C., Breiding, D. E., Sverdrup, F., Richard, J., and Androphy, E. J.
(2000) J Virol 74, 5872-5879
43. Zhang, J., Kalkum, M., Chait, B. T., and Roeder, R. G. (2002) Mol Cell 9,
611-623
44. Ouyang, H., Nussenzweig, A., Kurimasa, A., Soares, V. C., Li, X., Cordon-
Cardo, C., Li, W., Cheong, N., Nussenzweig, M., Iliakis, G., Chen, D. J.,
and Li, G. C. (1997) J Exp Med 186, 921-929
45. Ferguson, D. O., Sekiguchi, J. M., Chang, S., Frank, K. M., Gao, Y.,
DePinho, R. A., and Alt, F. W. (2000) Proc Natl Acad Sci U S A 97, 6630-
6633
46. Pierce, A. J., Hu, P., Han, M., Ellis, N., and Jasin, M. (2001) Genes Dev
15, 3237-3242
47. Tuteja, N., Tuteja, R., Ochem, A., Taneja, P., Huang, N. W., Simoncsits,
A., Susic, S., Rahman, K., Marusic, L., Chen, J., and et al. (1994) Embo J
13, 4991-5001
48. Manis, J. P., Gu, Y., Lansford, R., Sonoda, E., Ferrini, R., Davidson, L.,
Rajewsky, K., and Alt, F. W. (1998) J Exp Med 187, 2081-2089
49. Um, J. H., Kim, S. J., Kim, D. W., Ha, M. Y., Jang, J. H., Chung, B. S.,
Kang, C. D., and Kim, S. H. (2003) Mech Ageing Dev 124, 967-975
50. Goedecke, W., Eijpe, M., Offenberg, H. H., van Aalderen, M., and Heyting,
C. (1999) Nat Genet 23, 194-198
51. Hsia, K. T., Millar, M. R., King, S., Selfridge, J., Redhead, N. J., Melton, D.
W., and Saunders, P. T. (2003) Development 130, 369-378
by guest on June 11, 2020http://w
ww
.jbc.org/D
ownloaded from
Cyclin A1 Interaction Partners
- 37 -
52. Pitcher, J. A., Inglese, J., Higgins, J. B., Arriza, J. L., Casey, P. J., Kim,
C., Benovic, J. L., Kwatra, M. M., Caron, M. G., and Lefkowitz, R. J.
(1992) Science 257, 1264-1267
53. Ron, D., Chen, C. H., Caldwell, J., Jamieson, L., Orr, E., and Mochly-
Rosen, D. (1994) Proc Natl Acad Sci U S A 91, 839-843
54. Chang, B. Y., Harte, R. A., and Cartwright, C. A. (2002) Oncogene 21,
7619-7629
55. Chang, B. Y., Conroy, K. B., Machleder, E. M., and Cartwright, C. A.
(1998) Mol Cell Biol 18, 3245-3256
56. Croze, E., Usacheva, A., Asarnow, D., Minshall, R. D., Perez, H. D., and
Colamonici, O. (2000) J Immunol 165, 5127-5132
57. Ozaki, T., Watanabe, K., Nakagawa, T., Miyazaki, K., Takahashi, M., and
Nakagawara, A. (2003) Oncogene 22, 3231-3242
58. Jackson, F. R., Banfi, S., Guffanti, A., and Rossi, E. (1997) Genomics 41,
444-452
59. Lai, M. C., Kuo, H. W., Chang, W. C., and Tarn, W. Y. (2003) Embo J 22,
1359-1369
60. Elliott, D. J., Millar, M. R., Oghene, K., Ross, A., Kiesewetter, F., Pryor, J.,
McIntyre, M., Hargreave, T. B., Saunders, P. T., Vogt, P. H., Chandley, A.
C., and Cooke, H. (1997) Proc Natl Acad Sci U S A 94, 3848-3853
61. Herrmann, C. H., and Mancini, M. A. (2001) J Cell Sci 114, 1491-1503
62. Dickinson, L. A., Edgar, A. J., Ehley, J., and Gottesfeld, J. M. (2002) J Biol
Chem 277, 25465-25473
63. Seghezzi, W., Chua, K., Shanahan, F., Gozani, O., Reed, R., and Lees, E.
(1998) Mol Cell Biol 18, 4526-4536
by guest on June 11, 2020http://w
ww
.jbc.org/D
ownloaded from
Cyclin A1 Interaction Partners
- 38 -
FIGURE LEGENDS
Fig. 1: Yeast-Triple-Hybrid System for cyclin A1/CDK2 interaction partners
1A: A Yeast-Triple-Hybrid System (Y3H) was used to identify interaction
partners of the cyclin A1/CDK2 complex from a testis cDNA library. Cyclin A1
served as bait fused to the GAL4-DNA-Binding Domain (BD), CDK2 was
coexpressed from the same vector and the testis cDNA library was fused to the
GAL4-Activation Domain (AD). Yeast growth only occurred upon interaction of
cyclin A1, CDK2 and a library cDNA. 1B: Eight genes were identified in more
than a single yeast clone. Three of them encoded novel proteins named INCA1,
KARCA1 and PROCA1.
Fig. 2: Sequences of the novel proteins INCA1, KARCA1 and PROCA1
2A: The mRNA of human INCA1 encoded a 221 aa protein which was not
homologous to any other known protein. The mRNA consisted of eight exons of
which the second one was alternatively spliced leading to mRNAs of 1383 nt and
1221 nt length, respectively (NLS = Nuclear Localization Signal). 2B: KARCA1
was a novel protein of 288 aa that showed homology to Kelch motifs and Ankyrin
repeats. 2C: PROCA1 encoded a novel amino acid sequence interacting with
cyclin A1 in our Y3H assay. The identified clone spanned 133 aa and was in
frame to the GAL4-AD. As the protein sequence did not start with a methionine
and did not contain any STOP codon, we assume the full-length protein to be
larger and therefore called this sequence partial coding sequence. The N-
terminal part of PROCA1 contained a proline-rich region.
by guest on June 11, 2020http://w
ww
.jbc.org/D
ownloaded from
Cyclin A1 Interaction Partners
- 39 -
Fig. 3: Association of cyclin A1 with its novel interaction partners and substrates
3A: This figure shows the open reading frames of the identified cyclin A1-
interacting proteins and the parts of these proteins identified in the Y3H system
which constitute potential interaction domains. In addition, minimal and full
consensus motifs for CDK phosphorylation are displayed. 3B: In GST pulldown
assays, we proved interaction of all identified potential interaction partners with
cyclin A1 in vitro. GST alone or GST fused to one of the interacting proteins was
incubated with in vitro transcribed / translated radioactively labeled cyclin A1.
3C: Co-Immunoprecipitation of Myc-GPS2 with Cyclin A1 in lysates from
transfected Cos-7 cells confirmed their interaction in vivo. 3D: In in vitro kinase
assays, GST fusion proteins were incubated with lysates from baculovirally
infected Sf9 cells expressing cyclin A1 and CDK2 in the presence of [γ-32P]ATP.
3E: INCA1, Ku70 and RBM4 were phosphorylated by the cyclin A1/CDK2
complex. To control the specificity of their phosphorylation, GST fusion proteins
were incubated with Sf9 lysates from cells infected with empty vector, cyclin A1
alone or CDK2 alone.
Fig. 4: Expression of cyclin A1 and its interaction partners in normal organs
4A-4I: In a panel of healthy human organs, mRNA expression levels were
determined by real-time quantitative RT-PCR. Amounts of cDNA were
standardized to the expression levels of the housekeeping gene GAPDH.
Expression levels were normalized to their expression in testis (testis=1) (4A:
cyclin A1, 4B: INCA1, 4C: GPS2, 4D: Ku70, 4E: RACK1/GNB2L1, 4F: RBM4,
4G: DKFZ p686G052, 4H: KARCA1, 4I: PROCA1). 4J: An overview over
expression of all genes in normal organs is given in logarithmic scale. The x-axis
represents expression in testis (1.00). Diagram bars below the x-axis indicate
by guest on June 11, 2020http://w
ww
.jbc.org/D
ownloaded from
Cyclin A1 Interaction Partners
- 40 -
lower gene expression than in testis, bars above the x-axis indicate higher
expression than in testis. The graph clearly shows high expression in testis for
all genes except RACK1/GNB2L1 and therefore illustrates the testis-specific
expression pattern of most genes identified in our Y3H system.
Fig. 5: Expression of cyclin A1 and its interaction partners during testis
maturation and spermatogenesis and in testes with decreased fertility
5A: We analyzed previously published microarray data (35) for the expression of
the murine homologs of cyclin A1 and its interacting proteins throughout testis
development. Consecutive testis cDNA samples from day 1 after birth to adult
testis were hybridized to oligonucleotide microarrays. To allow easier
comparison of expression levels between different genes and to illustrate the
gene regulation throughout testicular maturation, gene expression levels were
normalized to the maximal expression level of each gene. Identical patterns of
induction were found for cyclin A1, KARCA1 and GPS2. Substantial expression
of all genes was confirmed in later stages of testis development when highest
cyclin A1 expression occurred. 5B: Gene expression levels were analyzed in
cDNA isolated from normal testis (n=6) and testis infertility patient samples
(n=35) by real-time quantitative RT-PCR. Mean expression levels and standard
errors are shown. Expression of seven genes differed significantly in normal and
malignant testis tissue.
Fig. 6: Expression of cyclin A1 and its interaction partners in testis tumors
6A: Gene expression levels were analyzed in cDNA isolated from normal testis
(n=7) and testis tumor patient samples (n=29) by real-time quantitative RT-PCR.
Mean expression levels and standard errors are shown. Expression of seven
by guest on June 11, 2020http://w
ww
.jbc.org/D
ownloaded from
Cyclin A1 Interaction Partners
- 41 -
genes differed significantly in normal and malignant testis tissue. 6B-6J:
Differentiation of the tumor samples into different histological subtypes is
presented in boxplots: normal testis (n=7), embryonal carcinoma (EC, n=6),
immature teratoma (iT, n=4), yolc-sac tumor (YS, n=3), seminoma (S, n=7),
mature teratoma (mT, n=6).
Fig. 7: Interaction and phosphorylation of INCA1 by cyclin A1
7A: GST pulldown assays of GST-INCA1 and cyclin A1 from either baculovirus-
infected Sf9 cell lysate or in vitro transcription/translation confirmed binding of
INCA1 and cyclin A1 in vitro. 7B: Cos-7 cells were transfected with EGFP-cyclin
A1 and Myc-INCA1. Immunoprecipitation with α-Myc antibody and subsequent
Western blotting for EGFP-cyclin A1 indicated interaction of cyclin A1 and INCA1
in vivo. ML-1 leukemia cells which express high levels of cyclin A1 were serum
starved to induce INCA1 expression. Immunoprecipitation was performed on
equal amounts of protein lysate with α-INCA1 immune serum or with pre-immune
serum for control purposes. Western blotting for cyclin A1 revealed interaction of
endogenous cyclin A1 with endogenous INCA1 in starved ML-1 cells. The higher
non-specific band ( ) is shown as a loading control. 7C: In vitro kinase assays
with GST-INCA1 and lysates from baculovirus-infected Sf9 cells were carried out
in the presence of [γ−32P]ATP. As with cyclin A1/CDK2 (compare Fig. 3E), GST-
INCA1 was phosphorylated in vitro by cyclin A2/CDK2, but not by CDK2 or either
cyclin alone. 7D: Three INCA1 fragments were fused to GST and used for in
vitro kinase assays. The C-terminal part of INCA1 was predominantly
phosphorylated by cyclin A1/CDK2. 7E: Potential phosphorylation sites were
point mutated to alanine. Mutation of Ser23, Thr167 and Ser176 strongly reduced in
by guest on June 11, 2020http://w
ww
.jbc.org/D
ownloaded from
Cyclin A1 Interaction Partners
- 42 -
vitro phosphorylation of INCA1. Equal concentration of GST fusion proteins was
confirmed by SDS-PAGE and Coomassie-staining (not shown).
Fig. 8: Expression of INCA1 mRNA and protein in vivo
8A: Northern blot analysis of total mRNA from different species (Macaca
fascicularis (M.f.), Callithrix jacchus (C.j.), Homo sapiens (H.s.) and Mus
musculus (M.m.)) showed the existence of INCA1 mRNA in vivo. Two bands
corresponding to the two splice variants were seen in human and monkey
organs with highest expression levels in the testis. 8B: Transfection of the cDNA
of INCA1 into Sf9 insect cells and into the mammalian cell line Cos-7 led to the
expression of INCA1 protein detected by Western blotting. 8C: Several cell lines
were tested for INCA1 expression by Western blotting using antibodies affinity
purified with two different peptides of INCA1. Transfected Cos-7 cells were used
as positive control. 8D: Cos-7 cells were transfected with EGFP or EGFP-INCA1
and stained for DNA (DAPI) and Actin (TRITC-Phalloidin). 8Da: The staining
pattern of EGFP (green) was predominantly localized in the cytosol and co-
stained with Actin (red) rather than with DNA (blue). 8Db: Fluorescence of EGFP
fused to human INCA1 was localized in the nucleus. 8Dc+d: Confocal laser
scanning microscopy gave a more detailed picture of localization and revealed a
non-homogenous nuclear staining pattern for INCA1.
Fig. 9: INCA1 gene expression is driven by a Sp1-dependent promoter
9A: Fragments of the genomic sequence upstream of the INCA1 transcriptional
start site were cloned into the promoter position upstream of a luciferase cDNA.
Luciferase assays after transfection into Cos-7 cells showed high promoter
activity for a 1.6 kb and a 0.6 kb fragment. 9B: In Sp1-deficient S2 insect cells,
by guest on June 11, 2020http://w
ww
.jbc.org/D
ownloaded from
Cyclin A1 Interaction Partners
- 43 -
no promoter activity was detected whereas co-transfection of the transcription
factor Sp1 led to strong activation of the INCA1 promoter fragments. 9C: The 0.6
kb fragment of the INCA1 promoter contained several putative Sp1 binding sites.
Deletional mutation of this fragment revealed the importance of the sequence -
254/+97 for Sp1-dependent promoter activation in luciferase assays. 9D: HeLa
cells were treated with 5-aza-Cytidine (Aza) or the HDAC inhibitor Trichostatin A
(TSA) and INCA1 mRNA expression was analyzed by real-time quantitative RT-
PCR. TSA treatment induced INCA1 expression whereas Aza had no effect on
the INCA1 promoter.
Supplementary Fig. 1: Sequence, genomic localization and structure of INCA1
S1A: The mRNA of human INCA1 encoded a 221 aa protein which was not
homologous to any other known protein. The mRNA consisted of eight exons of
which the second one was alternatively spliced leading to mRNAs of 1383 nt and
1221 nt length, respectively. Human INCA1 localized to chromosome 17p13.
S1B: The murine homolog of INCA1 encoded a 231 aa protein and contained
seven exons. The first exon was alternatively spliced giving rise to four splice
variants. The murine INCA1 gene mapped to chromosome 11B.
by guest on June 11, 2020http://w
ww
.jbc.org/D
ownloaded from
Cyclin A1 Interaction Partners
- 44 -
SUPPLEMENTS
Supplementary Table 1: Primer and probes for Yeast colony PCR, quantitative
real-time RT-PCR (TaqMan) and mutagenesis
forward primer reverse primer TaqMan probe
Yeast colony PCR first PCR
ATACCACTACAATGGATG CAGTTGAAGTGAACTTGCGGGG
Yeast colony PCRnested PCR
CTATTCGATGAAGATACCCCACCAAACCC
GTGAACTTGCGGGGTTTTTCAGTATCTACGAT
TaqMan GAPDH GAAGGTGAAGGTCGGAGTC GAAGATGGTGATGGGATTTC CAAGCTTCCCGTTCTCAGCC
TaqMan Cyclin A1 GGGCTCCCAGATTTCGTCT CTGCAGTGCATTGCTTCAGA CCAGCAGCAGCCCGTGGA
TaqMan INCA1 cds GCAGGTGCAGGATGATGG A GAGATCGGCTGACCACCCT CAACCTCATCCCCTTTGCCAAGTGTTC
TaqMan INCA1 5'UTR CCTGGCTTCCTTCAGCTCC CACCTGCATGACTGGACGG TGGATCTAGCACCAAAAAGGAGACTAACTAC
TaqMan GPS2 AAAAACGGAGGCGAAAGGA GTGTGAACAGTCAGGCTCTGCT
CAGAGTGACCTGACCACCCTAACATCAGC
TaqMan Ku70 GCCTTGGCCTTGGATTTGAT CCCAGTCTTTTATTCATTGCTTCA
TaqMan GNB2L1 = RACK1
TGGGATGGAACCCTGCG GTATGGCCCACAAATCGCC
TaqMan RBM4 GGCGCGGTACTCAGCCTT CAACCGCAGCTCGGAATTT
TaqMan DKFZ p686G052
AATTTAGTGGTACTGATTTGCTTAATGG
GTAGAATGTGGTGAGACAACTACACTTG
TaqMan KARCA1 GCACCTATTGCTACAAGCAAGAAG GAGCAGGGCCGCACAGT
TaqMan PROCA1 GCTGGTGTGGCGTCCAC AGCAGCACTTGTCAGGCTCC
hINCA1 S23A GGTCAGCCGAGCTCCACCCCCAAGG
CCTTGGGGGTGGAGCTCGGCTGACC
hINCA1 T167A CCGTTTTCTCGCTCCCGGCAGGGCC
GGCCCTGCCGGGAGCGAGAAAACGG
hINCA1 S176A CCAGCTGCTTTGGGCTCCCTGGAGC
GCTCCAGGGAGCCCAAAGCAGCTGG
hINCA1 S179A CTTTGGTCTCCATGGGCCCCCCTGG
CCAGGGGGGCCCATGGAGACCAAAG
All sequences are given in 5'-3' direction. TaqMan probes were labeled at the 5'
end with the fluorescent dye FAM (GAPDH: VIC) and at the 3' end with the
quencher TAMRA.
by guest on June 11, 2020http://w
ww
.jbc.org/D
ownloaded from
Cyclin A1 Interaction Partners
- 45 -
Supplementary Table 2: GenBank Accession Numbers for the novel genes
INCA1, KARCA1 and PROCA1
Gene Species Molecule Accession Number
INCA1 Homo sapiens mRNA, splice isoform 1 AY601906
INCA1 Homo sapiens mRNA, splice isoform 2 AY601907
INCA1 Homo sapiens coding sequence AY601908
INCA1 Mus musculus mRNA, splice isoform 1 AY601909
INCA1 Mus musculus mRNA, splice isoform 2 AY601910
INCA1 Mus musculus mRNA, splice isoform 3 AY601911
INCA1 Mus musculus mRNA, splice isoform 4 AY601912
INCA1 Mus musculus coding sequence AY601913
KARCA1 Homo sapiens mRNA AY601914
KARCA1 Homo sapiens coding sequence AY601915
PROCA1 Homo sapiens partial mRNA AY601916
by guest on June 11, 2020http://w
ww
.jbc.org/D
ownloaded from
Cyclin A1 Interaction Partners
- 46 -
Supplementary Table 3: Bioinformatical analyses of the INCA1 sequence
For the analysis of the nucleotide and the amino acid sequence of INCA1,
several web-based resources were used. Detailed information about these
programs is listed in supplementary table 3A. Results and predicted properties of
INCA1 are shown in Table 3B.
Analyzed property Program ResourceBlast http://www.ncbi.nlm.nih.govWU-blastp http://www.ebi.ac.ukScanps http://www.ebi.ac.uk
Homology searches
BLAST2.0 http://www.ch.embnet.orgProtein parameters ProtParam http://www.expasy.ch/cgi-bin/protparam
Scan Prosite http://www.expasy.ch/cgi-bin/scanprositePosttranslationalmodifications Motif Scan http://hits.isb-sib.ch/cgi-bin/PFSCAN
PhosphoBase http://www.cbs.dtu.dk/databases/PhosphoBase- Phosphorylation
NetPhos 2.0 http://www.cbs.dtu.dk/services/NetPhos/- Tyr sulfation Sulfinator http://www.expasy.ch/cgi-bin/sulfinator.pl-Glycosylation NetOGlyc 2.0 http://www.cbs.dtu.dk/services/NetOGlyc/
big-PI predictor http://mendel.imp.univie.ac.at/gpi/cgi-bin/gpi_pred.cgi- GPI anchor
DGPI http://129.194.186.123/servlet_dgpi/dgpi
Localization & Signalsequences PSORT II http://psort.nibb.ac.jp/cgi-bin/runpsort.pl
Domain search S.M.A.R.T. http://smart.embl-heidelberg.de/smart- transmembrane
d iTMPred http://www.ch.embnet.org/cgi-bin/TMPRED_form_parser
Stability ProtParam http://www.expasy.ch/cgi-bin/protparam- PEST sequences PESTfind http://vienna.at.embnet.org/htbin/embnet/ PESTfind
http://genome.ucsc.eduChromosomallocalization http://www.ncbi.nlm.nih.gov/Genome
Table 3A: Bioinformatic tools for the analysis of the INCA1 sequence
by guest on June 11, 2020http://w
ww
.jbc.org/D
ownloaded from
Cyclin A1 Interaction Partners
- 47 -
Property ResultsHomologysearches no significant homology on the nucleotide or amino acid level
hINCA1 221 aaMW hINCA1
I25201.5 Da
pI hINCA1 6.92mINCA1 231 aaMW mINCA1
I26476.8 Da
Protein parameters
pI mINCA1 7.7Kinase # sitesPosttranslational
modifications Calmodulin II 3Protein Kinase A 3Casein Kinase I 2Casein Kinase II 1CDK 1Protein Kinase G 1
Phosphorylation
Protein Kinase C 1N-Myristoylation 92-97, 124-129, 213-218 3Tyr sulfation Tyr148 1Glycosylation Ser32 1only sites with high
potential (90%) of modification are shown GPI anchor - 0
Transmembrane Helices - 0Nuclear Localization Signal RRKKRRP (75-81) 1Other signal sequences - 0
Localization & Signal sequences
Predicted localization nuclearDomain search -
Destabilizing signals -Stability
Instability index 85.12 (unstable)hINCA1 chromosome 17p13.3Chromosomal
localization mINCA1 chromosome 11B3
Table 3B: Results and predictions from the sequence analysis of hINCA1
The nucleotide and amino acid sequence of hINCA1 and mINCA1 were analyzed
using several web-based bioinformatic tools. Results for hINCA1 and mINCA1
were highly consistent.
by guest on June 11, 2020http://w
ww
.jbc.org/D
ownloaded from
Berdel, Hubert Serve and Carsten Müller-TidowE.Cauvet, Wenbing Wang, Jörg Gromoll, Mark G. Schrader, H. Phillip Koeffler, Wolfgang
Sven Diederichs, Nicole Bäumer, Ping Ji, Stephan K. Metzelder, Gregory E. Idos, ThomasIdentification of interaction partners and substrates of the cyclin A1/CDK2 complex
published online May 24, 2004J. Biol. Chem.
10.1074/jbc.M401708200Access the most updated version of this article at doi:
Alerts:
When a correction for this article is posted•
When this article is cited•
to choose from all of JBC's e-mail alertsClick here
Supplemental material:
http://www.jbc.org/content/suppl/2004/07/08/M401708200.DC1
by guest on June 11, 2020http://w
ww
.jbc.org/D
ownloaded from